Cancer Immunity & Immunotherapy
Wednesday, June 20 at FOCIS 2018
Abul K. Abbas, MD
Leisha A Emens, MD, PhD
|Rate||One Course||Two Course Package|
|Trainee/Medical Student Member||$165||$250|
|Trainee/Medical Student Non-member||$195||$280|
Join FOCIS to take advantage of the reduced course registration rate and much more!
The purpose of this course is to review tumor immunology as the scientific foundation for the current practice of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations, and near-term opportunities for further accelerating clinical progress.
This course is designed for translational researchers and scientists, practicing clinicians, trainees, and indviduals in biotechnology and pharmaceutical companies interested in immuno-oncology and the development of immunotherapies for cancer.
Completion of this course, will allow participants to:
|Wednesday, June 20|
|8:00am - 9:00am||The Mechanistic Basis of Cancer Immunotherapy- Leisha Emens, MD, PhD|
|9:00am - 9:40am||Manipulating the Tumor Environment (DCs, Tregs, others) - Max Krummel, PhD|
|9:40am - 10:00am||Break
|10:00am-10:40am||CAR-T Cell Therapy: Principles and Current Practices - Crystal Mackall, MD|
|10:40am - 11:20am||CAR-T Cell Therapy: Next Generation CARs Toxicities, Challenges and Prospects - Crystal Mackall, MD
|11:20am-12:00pm||T-cell Receptor Transduced T-cells - Cassian Yee, MD
|12:00pm - 12:45pm||Lunch with Faculty|
|12:45pm - 1:30pm||Checkpoint Blockade Therapy: Current Status & Biomarkers - Ira Mellman, PhD
|1:30pm - 2:10pm||Next Generation Checkpoint and Combination Therapies - Ira Mellman, PhD
|2:10pm - 2:50pm||Focus on Engineered Antibodies (bispecific antibodies, antibody-cytokine fusions and other types of armed antibody products) - Dario Neri, PhD|
|2:50pm - 3:30pm||Immune-Related Toxicity: Mechanisms and Management - Kevan Herold, MD|
|3:30pm - 3:45pm||Break|
|3:45pm - 4:30pm||Vaccination Strategies, Identification of Neoantigens - Lisa Butterfield, PhD|
|4:30pm - 5:00pm||Future Prospects and Challenges in Cancer Immunotherapy - Jeffrey Bluestone, PhD|
FOCIS will not offer CME credit for any course or session at FOCIS 2018. Certificates of attendance will be available upon request.